Elevance Health (NYSE:ELV) PT Lowered to $535.00 at JPMorgan Chase & Co.

Elevance Health (NYSE:ELV – Free Report) had its target price decreased by JPMorgan Chase & Co. from $572.00 to $535.00 in a research report report published on Friday, FlyOnTheWall reports. A number of other analysts also recently issued reports on ELV. TD Cowen lowered their price target on Elevance Health from $577.00 to $564.00 and […]

Related Keywords

,Adviser Investments ,Elevance Health Company Profile ,Elevance Health ,Jpmorgan Chase Co ,News Ratings For Elevance Health Daily ,Wells Fargo Company ,Analyst Recommendations For Elevance Health ,Sumitomo Life Insurance Co ,Elevance Health Inc ,Elevance Health Price Performance ,Cantor Fitzgerald ,Lederer Associates Investment Counsel ,Elevance Health Dividend Announcement ,Deutsche Bank Aktiengesellschaft ,Creative Financial Designs Inc ,Free Report ,Get Free Report ,Life Insurance ,Financial Designs ,Associates Investment Counsel ,Specialty Business ,Government Business ,Elevance Health Daily ,Nyse Elv ,Elv ,Medical ,94973v10 ,Lower Price Target ,